Next-Generation Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

By Technology (Next-generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), By Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function (Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), By Region, and By Competition

Published	Pages	Publisher	Report code
Nov 2023	170	TechSci Research	ASDR-642606

Published: Nov 2023 - Pages : 170 - Publisher : TechSci Research - Report code : ASDR-642606

1. Janssen Pharmaceuticals Inc
2. Novartis AG
3. F Hoffmann-La Roche AG
4. Koninklijke Philips NV
5. Abbott Laboratories Inc
6. GE Healthcare Inc
7. Thermo Fisher Scientific Inc
8. Agilent Technologies Inc
9. Illumina Inc
10. QIAGEN NV

Global Colorectal Cancer Screening and Diagnostics Market

This report can be of interest as well:

Global Colorectal Cancer Screening and Diagnostics Market

Published: February, 2025 | Report code: ASDR-674434